NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are a
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE: PBH).  Such
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH).  Such investors ar
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. (“Prestige” or the “Company”) (NYSE: PBH).  Such i
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Prestige Consumer Healthcare Inc. (NYSE: PBH) ("Prestige Consumer
LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer
LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Prestige Consumer
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Cons
Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: [url=
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) investor
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of inves
Prestige Consumer Healthcare shares fell sharply after Q4 earnings missed consensus estimates -- adjusted EPS came in at $1.23 versus the $1.39 expected, driven by unresolved supply-chain constraints
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Prestige Consumer Healthcare Inc. ("Prestige" or the "Company") (NYSE: PBH). Such investors are a
NEW YORK--(BUSINESS WIRE)--Shareholders who lost money on Prestige Consumer Healthcare (NYSE: PBH) stock following the Company's Q4 FY 2026 earnings miss are encouraged to submit their information to
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE